European BiotechNovo Nordisk Exits Internal Cell Therapy, Licenses Parkinson's Program to AI PartnerSalvado•Jun 25, 2026
European Corporate StrategyLakefront Biotherapeutics Closes Ouro Acquisition, Retains €2B War Chest for Further DealsSalvado•Jun 7, 2026
